Pharma groups plan anti-diarrhoea vaccine

Europe is getting closer to finding a painless riposte to Moctezuma’s revenge, after two pharmaceutical companies on Friday signed a deal to develop a needle-free vaccination against travellers’ diarrhoea.

GlaxoSmithKline of the UK, one of the world’s largest vaccine producers, has put its weight behind an experimental vaccine that needs no syringe, developed by Intercell of Austria.